+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter



Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter



Journal of Ethnopharmacology 112(3): 498-506



A petroleum ether extract (FP) from Fructus Psoraleae, seeds of Psoralea corylifolia L. (Leguminosae), was found to strongly inhibit dopamine (DA) uptake by dopamine transporter (DAT) heterogeneously expressed cells (D8 cells) and noradrenaline (NE) uptake by noradrenaline transporter (NET) heterogeneously expressed cells, which, however, had no effect on gamma-aminobutyric acid transporter heterogeneously expressed cells and serotonin transporter heterogeneously expressed cells at the concentration up to 100 microg/ml. These inhibitory effects were also confirmed by experiments on SK-N-SH cell line and synaptosomes from rats' brains. In addition, FP showed a significantly mitigating effect on 1-methyl-4-pyridinium induced injury of D8 cells. Meanwhile, FP dose-dependently reduced the binding of tritium-labeled cocaine analog (-)-2beta-carbomethoxy-3beta-(4-fluorophenyl) tropane to DAT of D8 cells, which suggests that FP may inhibit DAT activity in the same way as cocaine does. Behavioral study showed FP had a long-lasting stimulant effects on the activity of intact mice and reserpinized mice. So FP is proposed as a kind of DAT and NET inhibitor and may be involved in the process of regulating the DA and NE system, and FP or its unknown bioactive compounds may be developed into new medicines for disorders such as Parkinson's disease, depression, Attention Deficit Hyperactivity Disorder (ADHD) or cocaine addiction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 014082985

Download citation: RISBibTeXText

PMID: 17555897

DOI: 10.1016/j.jep.2007.04.013


Related references

Substitution of carboxyl tail of bovine dopamine transporter for human dopamine transporter attenuates substrate transport and cocaine binding in human dopamine transporter. Society for Neuroscience Abstracts 23(1-2): 407, 1997

Effects of fructus psoraleae extract on the intestinal absorption kinetics of geniposide and geniposidic acid in rat. Molecules 19(6): 7557-7567, 2015

Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behavioural Pharmacology 19(5-6): 566-574, 2008

The releasing action of amphetamine via the human noradrenaline transporter Differences to the human dopamine transporter. Journal of Neurochemistry 69(SUPPL ): S71, 1997

Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity. Molecular Nutrition and Food Research 54(4): 516-524, 2010

Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 162(4): 870-880, 2009

Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. Synapse 61(7): 573-576, 2007

Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. European Journal of Pharmacology 389(1): 59-65, Feb 11, 2000

Aging effects on locomotor activity in dopamine transporter and vesicular monoamine transporter knockout mice. Society for Neuroscience Abstracts 26(1-2): Abstract No -344 5, 2000

Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain. Experimental Neurology 188(2): 387-390, 2004

Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade. Journal of Neurochemistry 98(1): 113-121, 2006

Systemic effect of Fructus Psoraleae extract on bone in mice. PhytoTherapy Research 24(10): 1578-1580, 2011

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. Journal of Pharmacology and Experimental Therapeutics 309(3): 959-969, 2004

Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain. Plos One 7(11): E49483, 2013